Yes, senolytics have shown potential in cancer therapy. By clearing the tumor microenvironment of senescent cells, senolytics may reduce tumor growth and improve the efficacy of conventional therapies. Research has demonstrated that senolytics can enhance the response to chemotherapy and reduce relapse rates by preventing the accumulation of therapy-induced senescent cells, which can contribute to cancer recurrence.
